Medical technology firm Lifeward Ltd. (LFWD) announced Thursday that it has received 510(k) FDA clearance for the newest generation of its personal exoskeleton device, the ReWalk 7.
The seventh generation of the ReWalk, a wearable exoskeleton that allows individuals with spinal cord injury (SCI) to stand and walk again, includes a number of new features, as well as enhancements and upgrades.
Lifeward will begin sales of the ReWalk 7 in the United States as soon as the product is available.
For comments and feedback contact: editorial@rttnews.com
Business News
Slide Shows